Patent Expiry – July 2020
The following list relates to patents, of the more commonly used brands, that are expected to expire.
Expiry dates may be extended by the drug companies.
|Generic Name||Anticipated Patent Expiry||Brand|
|Aliskiren tablets||Apr 2020||Rasilez|
|Rotigotine patch||Feb 2021||Neupro|
|Tapentadol tablets||Feb 2021||Palexia|
|Prucalopride tablets||May 2021||Resolor|
|Beclometasone + Formoterol inhaler||Jul 2021||Fostair|
|Varenicline tablets||Sep 2021||Champix|
|Amlodipine + Valsartan tablets||Dec 2021||Exforge|
|Exenatide injection (Byetta® only)||Nov 2021||Byetta|